The DOI matches its Crossref record; 219 of the 219 references it cites were found in a registry or an index.
Achondroplasia: Development, pathogenesis, and therapy
Open accessAbstract
Autosomal dominant mutations in fibroblast growth factor receptor 3 (FGFR3) cause achondroplasia (Ach), the most common form of dwarfism in humans, and related chondrodysplasia syndromes that include hypochondroplasia (Hch), severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN), and thanatophoric dysplasia (TD). FGFR3 is expressed in chondrocytes and mature osteoblasts where it functions to regulate bone growth. Analysis of the mutations in FGFR3 revealed increased signaling through a combination of mechanisms that include stabilization of the receptor, enhanced dimerization, and enhanced tyrosine kinase activity. Paradoxically, increased FGFR3 signaling profoundly suppresses proliferation and maturation of growth plate chondrocytes resulting in decreased growth plate size, reduced trabecular bone volume, and resulting decreased bone elongation. In this review, we discuss the molecular mechanisms that regulate growth plate chondrocytes, the pathogenesis of Ach, and therapeutic approaches that are being evaluated to improve endochondral bone growth in people with Ach and related conditions. Developmental Dynamics 246:291–309, 2017. © 2016 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–219 of 219
Delayed bone age due to a dual effect of FGFR3 mutation in Achondroplasia
Pannier, S., Dambroise, E., Jonquoy, A., Benoist-Lasselin, C., Odent, T., Jaïs, J., Münnich, A., & Legeai‐Mallet, L. (2010) · Bone · doi:10.1016/j.bone.2010.07.020 · Cited by 34
Self-citationSun, C., Marcello, M., Li, Y., Mason, D., Lévy, R., & Fernig, D. G. (2016) · Open Biology · doi:10.1098/rsob.150277 · Cited by 31
Pinto, G., Cormier‐Daire, V., Merrer, M. F. L., Samara‐Boustani, D., Baujat, G., Fresneau, L., Viaud, M., Souberbielle, J., Pineau, J., & Polak, M. (2014) · Hormone Research in Paediatrics · doi:10.1159/000364807 · Cited by 29
Su, N. Y., Li, X., Tang, Y., Yang, J., Wen, X., Guo, J., Tang, J., Du, X., & Chen, L. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2839 · Cited by 29
Fenichel, I., Evron, Z., & Nevo, Z. (2006) · International Orthopaedics · doi:10.1007/s00264-006-0082-2 · Cited by 28
McEwen, D. G., Green, R. P., Naski, M. C., Towler, D. A., & Ornitz, D. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30934 · Cited by 27
Self-citationDisruption of a Sox9–β-catenin circuit by mutant Fgfr3 in thanatophoric dysplasia type II
Shung, C.-Y., Ota, S., Zhou, Z.-Q., Keene, D. R., & Hurlin, P. J. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds305 · Cited by 27
Smith, L. B., Dally, M., Sainz, R., Rodrigue, K., & Oberbauer, A. (2006) · Journal of Animal Science · doi:10.2527/jas.2006-255 · Cited by 25
Phenotype profile of a genetic mouse model for Muenke syndrome
Nah, H., Koyama, E., Agochukwu, N. B., Bartlett, S. P. P., & Muenke, M. (2012) · Child s Nervous System · doi:10.1007/s00381-012-1778-9 · Cited by 24
Pan, F., Liu, X.-G., Guo, Y.-F., Chen, Y., Dong, S., Qiu, C., Zhang, Z., Zhou, Q., Yang, T., Guo, Y., et al. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.44 · Cited by 23
Zhang, H., Kamiya, N., Tsuji, T., Takeda, H., Scott, G. J., Rajderkar, S., Ray, M. K., Mochida, Y., Allen, B. L., Lefèbvre, V., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006510 · Cited by 23
Self-citationThanatophoric dysplasia caused by double missense FGFR3 mutations
Pannier, S., Martinovic, J., Heuertz, S., Delezoide, A., Münnich, A., Schibler, L., Serre, V., & Legeai‐Mallet, L. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32880 · Cited by 22
Self-citationYin, Y., Ren, X., Smith, C. S., Guo, Q., Malabunga, M., Guernah, I., Zhang, Y., Shen, J., Sun, H. D., Chehab, N. H., et al. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.024760 · Cited by 21
Self-citationA new prescription for growth? Statins, cholesterol and cartilage homeostasis
Bush, J., Bérubé, N. G., & Beier, F. (2015) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2015.01.002 · Cited by 19
A second family with CATSHL syndrome: Confirmatory report of another unique FGFR3 syndrome
Escobar, L., Tucker, M., & Bamshad, M. J. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37676 · Cited by 19
Generation of Monoclonal Antibody Targeting Fibroblast Growth Factor Receptor 3
Gorbenko, O., Ovcharenko, G., Klymenko, T., Zhyvoloup, O. M., Gaman, N., Volkova, D., Gout, I. T., & Filonenko, V. V. (2009) · Hybridoma · doi:10.1089/hyb.2009.0018 · Cited by 15
Parafioriti, A., Bianco, S. D., Barisani, D., Armiraglio, E., Peretti, G., & Albisetti, W. (2009) · Journal of Orthopaedic Science · doi:10.1007/s00776-009-1355-6 · Cited by 14
Effect of the G375C and G346E Achondroplasia Mutations on FGFR3 Activation
He, L., Serrano, C. M., Niphadkar, N., Shobnam, N., & Hristova, K. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034808 · Cited by 12
Biologists abandon Popper at their peril
(2000) · doi:10.1002/(sici)1521-1878(200002)22:2
Cited by
Collett-Solberg, P. F., Ambler, G., Backeljauw, P. F., Bidlingmaier, M., Biller, B. M. K., Boguszewski, M. C. S., Cheung, P. T., Choong, C. S. Y., Cohen, L. E., Cohen, P., et al. (2019) · Hormone Research in Paediatrics · doi:10.1159/000502231 · Cited by 360
Jackson, M., Marks, L., May, G. H. W., & Wilson, J. B. (2018) · Essays in Biochemistry · doi:10.1042/ebc20170053 · Cited by 295
Fibroblast growth factors: key players in regeneration and tissue repair.
Maddaluno, L., Urwyler, C., & Werner, S. (2017) · Development · doi:10.1242/dev.152587 · Cited by 241
Martin, L., Kaci, N., Estibals, V., Goudin, N., Garfa-Traore, M., Benoist-Lasselin, C., Dambroise, E., & Legeai-Mallet, L. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddx374 · Cited by 51
Self-citation
Metadata
- Authors
- Ornitz, D. M., & Legeai‐Mallet, L.
- Venue
- Developmental Dynamics
- Publisher
- Wiley
- Published
- 2017-03-02
- Volume
- 246
- Issue
- 4
- Pages
- 291-309
- ISSN
- 1058-8388 (ISSN-L)
- 1097-0177
- OpenAlex
- W2561993249
- Cited by
- 259
- References
- 219
- FWCI
- 11.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.